Azenta, Inc. (AZTA)
NASDAQ: AZTA · Real-Time Price · USD
32.09
+2.88 (9.86%)
At close: Aug 13, 2025, 4:00 PM
32.08
-0.01 (-0.03%)
After-hours: Aug 13, 2025, 4:00 PM EDT
Azenta Revenue
Azenta had revenue of $143.94M in the quarter ending June 30, 2025, a decrease of -0.24%. This brings the company's revenue in the last twelve months to $668.82M, up 12.46% year-over-year. In the fiscal year ending September 30, 2024, Azenta had annual revenue of $656.32M, down -1.32%.
Revenue (ttm)
$668.82M
Revenue Growth
+12.46%
P/S Ratio
2.22
Revenue / Employee
$202,673
Employees
3,300
Market Cap
1.47B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 656.32M | -8.75M | -1.32% |
Sep 30, 2023 | 665.07M | 109.57M | 19.73% |
Sep 30, 2022 | 555.50M | 41.80M | 8.14% |
Sep 30, 2021 | 513.70M | 125.17M | 32.21% |
Sep 30, 2020 | 388.54M | 54.36M | 16.27% |
Sep 30, 2019 | Pro | Pro | Pro |
Sep 30, 2018 | Pro | Pro | Pro |
Sep 30, 2017 | Pro | Pro | Pro |
Sep 30, 2016 | Pro | Pro | Pro |
Sep 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
AZTA News
- 8 days ago - Azenta, Inc. (AZTA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Azenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 Guidance - PRNewsWire
- 13 days ago - Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology - PRNewsWire
- 13 days ago - Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care - PRNewsWire
- 14 days ago - Azenta to Participate in 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference - PRNewsWire
- 21 days ago - Azenta Announces Fiscal 2025 Third Quarter Earnings Conference Call and Webcast - PRNewsWire
- 3 months ago - Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development - PRNewsWire
- 3 months ago - Azenta, Inc. (AZTA) Q2 2025 Earnings Call Transcript - Seeking Alpha